Connection
Robert MacLaren to Midazolam
This is a "connection" page, showing publications Robert MacLaren has written about Midazolam.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
1.641 |
|
|
|
-
Farrar JE, Stefanos SS, Cava L, Kiser TH, Mueller SW, Neumann R, Reynolds PM, Sherman DS, MacLaren R. Correlation Between Serum and CSF Concentrations of Midazolam and 1-Hydroxy-Midazolam in Critically Ill Neurosurgical Patients. Ann Pharmacother. 2025 Mar; 59(3):244-249.
Score: 0.895
-
MacLaren R, Preslaski CR, Mueller SW, Kiser TH, Fish DN, Lavelle JC, Malkoski SP. A randomized, double-blind pilot study of dexmedetomidine versus midazolam for intensive care unit sedation: patient recall of their experiences and short-term psychological outcomes. J Intensive Care Med. 2015 Mar; 30(3):167-75.
Score: 0.424
-
MacLaren R, Sullivan PW. Pharmacoeconomic modeling of lorazepam, midazolam, and propofol for continuous sedation in critically ill patients. Pharmacotherapy. 2005 Oct; 25(10):1319-28.
Score: 0.242
-
MacLaren R. Immunosedation: a consideration for sepsis. Crit Care. 2009; 13(5):191.
Score: 0.080